@article{42822635f78940748270ad8b6c2526ca,
title = "New goals for viral suppression in HIV treatment in even the most experienced of patients",
author = "Sterling, \{Stephanie A.\} and Aberg, \{Judith A.\}",
note = "Funding Information: Dr. Sterling has received funding from Merck. Dr. Aberg has been a scientific advisor for Abbott, BMS, BI, Gilead, GlaxoSmithKline, Pfizer, Merck, and Tibotec. She has received clinical trial support from Abbott, BMS, Gilead, GlaxoSmithKline, Merck, Pfizer, Schering, Theratech-nologies, and Tibotec.",
year = "2009",
month = may,
doi = "10.1007/s11904-009-0008-x",
language = "English",
volume = "6",
pages = "51--52",
journal = "Current HIV/AIDS Reports",
issn = "1548-3568",
publisher = "Springer",
number = "2",
}